Previous 10 | Next 10 |
Management to Highlight Significant Opportunities with Recent Acquisition of Celularity’s UltraMIST Assets and Preview Plans for Balance of 2020 SUWANEE, GA, Aug. 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), whose focu...
Plans for Immediate Commercial Launch via Established Joint Venture SUWANEE, GA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of patented PACE® technology platform fo...
WARREN, N.J. , Aug. 20, 2020 /PRNewswire/ -- Celularity, Inc. ("Celularity" or "the Company") today announced that it has sold its UltraMIST® Ultrasound Healing Therapy asset to Sanuwave Health, Inc. [OTC PNK: SNWV] ("Sanuwave") in connection with which Celularity granted Sanuwa...
SUWANEE, GA, Aug. 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) announced today that the Company will host a conference call on Wednesday, August 12, 2020, beginning at 1PM Eastern Time to provide an update on the recently acquired wound care as...
Conference Call Scheduled for Wednesday 1:00 p.m. EDT SUWANEE, GA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that it has completed the acquisition of the wound care assets of Celularity, consisting of the Ultr...
SUWANEE, GA, July 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) (“SANUWAVE” or the “Company”) today announced the results from the Company’s 2020 Annual Meeting of Stockholders, held Thursday, July 23, 202...
Phoenix, Arizona--(Newsfile Corp. - July 1, 2020) - The Stock Day Podcast welcomed SANUWAVE Health, Inc. (OTCQB: SNWV) ("the Company"), a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for ...
Miami Beach, Florida--(Newsfile Corp. - June 23, 2020) - When it comes to finding value within emerging technologies, staying focused on the companies that fill a niche market opportunity can deliver substantial rewards. In the regenerative medicine products space, SANUWAVE Health (OTCQB: SNWV...
SUWANEE, Ga., June 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) is scheduled to participate in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 3:00pm ET (12:00...
SANUWAVE Health ( OTCQB:SNWV ) has entered into an exclusive, non-binding letter of intent to acquire privately held Celularity’s UltraMIST Ultrasound Healing Therapy asset as well as exclusive partnership rights for Celularity’s wound care biologic products. More news on: ...
News, Short Squeeze, Breakout and More Instantly...
SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...
Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE Health, Inc. (the “Company”...
SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to June 30, 2024 Combined entity has applied to list on Cboe BZX Exchange, Inc. EDEN PRAIRIE, MN - ( NewMediaWire ) - June 04, 2024 - SANUWAVE...